17/07/2024  17:30:08 Diferencia -3.40 Volumen Bid21:06:25 Ask21:06:25 Capitalización de mecado Dividendo A. P/E Ratio
267.80CHF -1.25% 228,615
Volumen de negocios: 60.82 millones
-Volumen de oferta: 25 -Tamaño/ Volumen/ Formato de Ask: 4 15.97 mil millonesCHF 1.61% 26.57

Descripción de negocio

Sonova, headquartered in Stäfa, Switzerland, is the leading manufacturer of innovative hearing care solutions. The Group operates through its core business brands Phonak, Unitron, Advanced Bionics and Connect Hearing. Sonova offers its customers one of the most comprehensive product portfolios in the industry – from hearing instruments to cochlear implants to wireless communication solutions. Founded in 1947, the Group is currently present in over 100 countries across the globe. Across all businesses, and by supporting the Hear the World Foundation, Sonova pursues its vision of a world where everyone enjoys the delight of hearing and therefore lives a life without limitations.
 

Consejo de gestión & Consejo de supervisión

CEO
Arnd Kaldowski
Consejo de gestión
Birgit Conix, Ludger Althoff, Robert Woolley, Lilika Beck, Oliver Lux, Katya Kruglova, Alistair Simpson
Consejo de supervisión
Robert F. Spoerry, Stacy Enxing Seng, Adrian Widmer, Lukas Braunschweiler, Lynn Dorsey Bleil, Roland Diggelmann, Ronald van der Vis, Julie Tay, Gilbert Achermann, Gregory Behar
 

Datos de la empresa

Nombre: Sonova Holding AG
Dirección: Laubisrütistraße 28,CH-8712 Stäfa
Teléfono: +41-58-928-0101
Fax: +41-58-928-2011
E-mail: info@sonova.com
Internet: www.sonova.com
Industria: Healthcare
Sector: Healthcare Providers
Subsector: Healthcare Providers
Fin del año financiero: 31/03
Acciones de libre circulación: 79.40%
Fecha de OPI: 01/11/1994

Relación con inversores

Nombre: Thomas Bernhardsgrütter
IR teléfono: +41-58-928-3344
IR-fax: +41 (58) 928 3399
IR e-mail: ir@sonova.com

Accionistas mayoritarios

Otros
 
71.38%
Beda Diethelm and Annamaria Diethelm-Pandiani
 
11.26%
Family of Hans-Ueli Rihs
 
6.18%
BlackRock, Inc.
 
5.10%
UBS Fund Management AG
 
3.06%
MFS Investment Management
 
3.02%